Elevated properdin and enhanced complement activation in first-degree relatives of South Asian subjects with type 2 diabetes

Diabetes Care

Volumn 35, Issue 4, 2012, Pages 894-899

  Somani, Riyaz ^a   Richardson, Victoria R ^a   Standeven, Kristina F ^a   Grant, Peter J ^a   Carter, Angela M ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; BIOLOGICAL MARKER; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; COMPLEMENT MEMBRANE ATTACK COMPLEX; PROPERDIN;

ADULT; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RELATIVE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SOUTH ASIA;

ADULT; ASIA, SOUTHEASTERN; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COMPLEMENT ACTIVATION; COMPLEMENT MEMBRANE ATTACK COMPLEX; DIABETES MELLITUS, TYPE 2; FAMILY; FAMILY HEALTH; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; PROPERDIN; RISK FACTORS; UP-REGULATION;

EID: 84862106278     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-1483     Document Type: Article

References (28)

1. Muscari A, Massarelli G, Bastagli L, et al. Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men. Eur Heart J 2000;21:1081-1090 (Pubitemid 30352992)
2. Engström G, Hedblad B, Eriksson KF, Janzon L, Lindgärde F. Complement C3 is a risk factor for the development of diabetes: a population-based cohort study. Diabetes 2005;54:570-575
3. Cianflone K, Xia Z, Chen LY. Critical review of acylation-stimulating protein physiology in humans and rodents. Biochim Biophys Acta 2003;1609:127-143 (Pubitemid 36120719)
4. Nishtar S. Prevention of coronary heart disease in south Asia. Lancet 2002;360:1015-1018 (Pubitemid 35284116)
5. Murphy C, Kanaganayagam GS, Jiang B, et al. Vascular dysfunction and reduced circulating endothelial progenitor cells in young healthy UK South Asian men. Arterioscler Thromb Vasc Biol 2007;27:936-942 (Pubitemid 46606728)
6. Somani R, Grant PJ, Kain K, Catto AJ, Carter AM. Complement C3 and C-reactive protein are elevated in South Asians independent of a family history of stroke. Stroke 2006;37:2001-2006 (Pubitemid 44309894)
7. Siezenga MA, Chandie Shaw PK, van der Geest RN, et al. Enhanced complement activation is part of the unfavourable cardiovascular risk profile in South Asians. Clin Exp Immunol 2009;157:98-103
8. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Increased insulin concentrations in nondiabetic offspring of diabetic parents. N Engl J Med 1988;319:1297-1301 (Pubitemid 19003390)
9. Mansfield MW, Heywood DM, Grant PJ. Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM. Circulation 1996;94:2171-2176 (Pubitemid 26360510)
10. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet 2005;366:1059-1062 (Pubitemid 41338752)
11. Laws A, Stefanick ML, Reaven GM. Insulin resistance and hypertriglyceridemia in nondiabetic relatives of patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1989;69:343-347 (Pubitemid 19208460)
12. Peake PW, Kriketos AD, Campbell LV, Charlesworth JA. Response of the alternative complement pathway to an oral fat load in first-degree relatives of subjects with type II diabetes. Int J Obes (Lond) 2005;29:429-435 (Pubitemid 40462767)
13. Peake PW, O'Grady S, Pussell BA, Charlesworth JA. Detection and quantification of the control proteins of the alternative pathway of complement in 3T3-L1 adipocytes. Eur J Clin Invest 1997;27:922-927 (Pubitemid 27483526)
14. Cianflone K, Maslowska M. Differentiation-induced production of ASP in human adipocytes. Eur J Clin Invest 1995;25:817-825
15. Kriketos AD, Greenfield JR, Peake PW, et al. Inflammation, insulin resistance, and adiposity: a study of first-degree relatives of type 2 diabetic subjects. Diabetes Care 2004;27:2033-2040 (Pubitemid 38989251)
16. Kemper C, Atkinson JP, Hourcade DE. Properdin: emerging roles of a pattern-recognition molecule. Annu Rev Immunol 2010;28:131-155
17. Ishigami T, Umemura S, Iwamoto T, et al. Molecular variant of angiotensinogen gene is associated with coronary atherosclerosis. Circulation 1995;91:951-954
18. Bongrazio M, Pries AR, Zakrzewicz A. The endothelium as physiological source of properdin: role of wall shear stress. Mol Immunol 2003;39:669-675 (Pubitemid 35454079)
19. Würzner R. Immunochemical measurement of complement components and activation products. Methods Mol Biol 2000;150:103-112
20. Harboe M, Ulvund G, Vien L, Fung M, Mollnes TE. The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation. Clin Exp Immunol 2004;138:439-446 (Pubitemid 39573623)
21. Harboe M, Garred P, Karlstrøm E, Lindstad JK, Stahl GL, Mollnes TE. The down-stream effects of mannan-induced lectin complement pathway activation depend quantitatively on alternative pathway amplification. Mol Immunol 2009;47:373-380
22. Ma XW, Chang ZW, Qin MZ, Sun Y, Huang HL, He Y. Decreased expression of complement regulatory proteins, CD55 and CD59, on peripheral blood leucocytes in patients with type 2 diabetes and macrovascular diseases. Chin Med J (Engl) 2009;122:2123-2128
23. Zhang J, Gerhardinger C, Lorenzi M. Early complement activation and decreased levels of glycosylphosphatidylinositol-anchored complement inhibitors in human and experimental diabetic retinopathy. Diabetes 2002;51:3499-3504 (Pubitemid 35403456)
24. Accardo-Palumbo A, Triolo G, Colonna-Romano G, et al. Glucose-induced loss of glycosyl-phosphatidylinositol-anchored membrane regulators of complement activation (CD59, CD55) by in vitro cultured human umbilical vein endothelial cells. Diabetologia 2000;43:1039-1047 (Pubitemid 30655724)
25. Mamane Y, Chung Chan C, Lavallee G, et al. The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation. Diabetes 2009;58:2006-2017
26. Wu G, Hu W, Shahsafaei A, et al. Complement regulator CD59 protects against atherosclerosis by restricting the formation of complement membrane attack complex. Circ Res 2009;104:550-558
27. Cole DS, Morgan BP. Beyond lysis: how complement influences cell fate. Clin Sci (Lond) 2003;104:455-466 (Pubitemid 36628141)
28. Zwaka TP, Torzewski J, Hoeflich A, et al. The terminal complement complex inhibits apoptosis in vascular smooth muscle cells by activating an autocrine IGF-1 loop. FASEB J 2003;17:1346-1348